Skip to content
PubMed This is a summary of 85 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 85 referenced papers

Top Authors

Robert William Taylor
Newcastle upon Tyne Hospitals NHS Foundation Trust
Robert McFarland
Newcastle upon Tyne Hospitals NHS Foundation Trust
Gráinne S. Gorman
Newcastle upon Tyne Hospitals NHS Foundation Trust
Douglass M. Turnbull
Newcastle upon Tyne Hospitals NHS Foundation Trust
Yi Shiau Ng
Newcastle upon Tyne Hospitals NHS Foundation Trust
Andrew M. Schaefer
Newcastle upon Tyne Hospitals NHS Foundation Trust
Nichola Zoe Lax
Wellcome Centre for Mitochondrial Research
Shamima Rahman
Great Ormond Street Hospital
Charlotte L. Alston
Newcastle upon Tyne Hospitals NHS Foundation Trust
Marni J. Falk
Children's Hospital of Philadelphia

Top Institutions

Ranked by publications Top 10 institutions
02

Wellcome Centre for Mitochondrial Research

Newcastle upon Tyne, United Kingdom

72 papers

References

References (85)
  1. 1

    MELAS syndrome: Clinical manifestations, pathogenesis, and treatment options.

    El-Hattab AW, Adesina AM, Jones J, Scaglia F

    Molecular genetics and metabolism 2015; (116(1-2)):4-12.

    PMID: 26095523
  2. 2

    Sudden adult death syndrome in m.3243A>G-related mitochondrial disease: an unrecognized clinical entity in young, asymptomatic adults.

    Ng YS, Grady JP, Lax NZ, et al.

    European heart journal 2016; (37(32)):2552-9 doi:10.1093/eurheartj/ehv306.

    PMID: 26188002
  3. 3

    Long-term cardiac prognosis and risk stratification in 260 adults presenting with mitochondrial diseases.

    Wahbi K, Bougouin W, Béhin A, et al.

    European heart journal 2015; (36(42)):2886-93 doi:10.1093/eurheartj/ehv307.

    PMID: 26224072
  4. 4

    Investigating complex I deficiency in Purkinje cells and synapses in patients with mitochondrial disease.

    Chrysostomou A, Grady JP, Laude A, et al.

    Neuropathology and applied neurobiology 2016; (42(5)):477-92 doi:10.1111/nan.12282.

    PMID: 26337858
  5. 5

    Speech changes after coordinative training in patients with cerebellar ataxia: a pilot study.

    Tykalova T, Pospisilova M, Cmejla R, et al.

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2016; (37(2)):293-6 doi:10.1007/s10072-015-2379-7.

    PMID: 26377098
  6. 6

    Epilepsy in adults with mitochondrial disease: A cohort study.

    Whittaker RG, Devine HE, Gorman GS, et al.

    Annals of neurology 2015; (78(6)):949-57 doi:10.1002/ana.24525.

    PMID: 26381753
  7. 7

    Perioperative considerations in adult mitochondrial disease: A case series and a review of 111 cases.

    Miyamoto Y, Miyashita T, Takaki S, Goto T

    Mitochondrion 2016; (26()):26-32.

    PMID: 26602285
  8. 8

    Metformin-associated lactic acidosis: Current perspectives on causes and risk.

    DeFronzo R, Fleming GA, Chen K, Bicsak TA

    Metabolism: clinical and experimental 2016; (65(2)):20-9.

    PMID: 26773926
  9. 9

    Ophthalmological findings in 74 patients with mitochondrial disease.

    Zhu CC, Traboulsi EI, Parikh S

    Ophthalmic genetics 2017; (38(1)):67-69 doi:10.3109/13816810.2015.1130153.

    PMID: 27029465
  10. 10

    Early Onset of Diabetes Mellitus Accelerates Cognitive Decline in Japanese Patients with Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Stroke-Like Episodes.

    Murakami T, Shinoto Y, Yonemitsu S, et al.

    The Tohoku journal of experimental medicine 2016; (238(4)):311-6 doi:10.1620/tjem.238.311.

    PMID: 27063563
  11. 11

    Renal Fanconi Syndrome Is Caused by a Mistargeting-Based Mitochondriopathy.

    Assmann N, Dettmer K, Simbuerger JMB, et al.

    Cell reports 2016; (15(7)):1423-1429 doi:10.1016/j.celrep.2016.04.037.

    PMID: 27160910
  12. 12

    The effect of a task-specific locomotor training strategy on gait stability in patients with cerebellar disease: a feasibility study.

    Im SJ, Kim YH, Kim KH, et al.

    Disability and rehabilitation 2017; (39(10)):1002-1008 doi:10.1080/09638288.2016.1177124.

    PMID: 27216372
  13. 13

    Audiological manifestations in mitochondrial encephalomyopathy lactic acidosis and stroke like episodes (MELAS) syndrome.

    Vandana VP, Bindu PS, Sonam K, et al.

    Clinical neurology and neurosurgery 2016; (148()):17-21.

    PMID: 27359089
  14. 14

    The meanings of physiotherapy and exercise for people living with progressive cerebellar ataxia: an interpretative phenomenological analysis.

    Cassidy E, Naylor S, Reynolds F

    Disability and rehabilitation 2018; (40(8)):894-904 doi:10.1080/09638288.2016.1277400.

    PMID: 28166646
  15. 15

    Use of dynamic movement orthoses to improve gait stability and trunk control in ataxic patients.

    Serrao M, Casali C, Ranavolo A, et al.

    European journal of physical and rehabilitation medicine 2017; (53(5)):735-743 doi:10.23736/S1973-9087.17.04480-X.

    PMID: 28627859
  16. 16

    Patient care standards for primary mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society.

    Parikh S, Goldstein A, Karaa A, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2017; (19(12)) doi:10.1038/gim.2017.107.

    PMID: 28749475
  17. 17

    Mitochondrial Disease in Children: The Nephrologist's Perspective.

    Pérez-Albert P, de Lucas Collantes C, Fernández-García MÁ, et al.

    JIMD reports 2018; (42()):61-70 doi:10.1007/8904_2017_78.

    PMID: 29249003
  18. 18

    Endocrine Disorders in Primary Mitochondrial Disease.

    Al-Gadi IS, Haas RH, Falk MJ, et al.

    Journal of the Endocrine Society 2018; (2(4)):361-373 doi:10.1210/js.2017-00434.

    PMID: 29594260
  19. 19

    mtDNA heteroplasmy level and copy number indicate disease burden in m.3243A>G mitochondrial disease.

    Grady JP, Pickett SJ, Ng YS, et al.

    EMBO molecular medicine 2018; (10(6)) doi:10.15252/emmm.201708262.

    PMID: 29735722
  20. 20

    Mitochondrial disease: an uncommon but important cause of diabetes mellitus

    Yee ML, Wong R, Datta M, et al.

    Endocrinology, diabetes & metabolism case reports 2018; (2018()) doi:10.1530/EDM-18-0091.

    PMID: 30306776
  21. 21

    Fanconi Syndrome.

    Foreman JW

    Pediatric clinics of North America 2019; (66(1)):159-167 doi:10.1016/j.pcl.2018.09.002.

    PMID: 30454741
  22. 22

    Cerebellar ataxia.

    Marsden JF

    Handbook of clinical neurology 2018; (159()):261-281 doi:10.1016/B978-0-444-63916-5.00017-3.

    PMID: 30482319
  23. 23

    Modulation of mtDNA copy number ameliorates the pathological consequences of a heteroplasmic mtDNA mutation in the mouse.

    Filograna R, Koolmeister C, Upadhyay M, et al.

    Science advances 2019; (5(4)):eaav9824 doi:10.1126/sciadv.aav9824.

    PMID: 30949583
  24. 24

    Management of bone disease in cystinosis: Statement from an international conference.

    Hohenfellner K, Rauch F, Ariceta G, et al.

    Journal of inherited metabolic disease 2019; (42(5)):1019-1029 doi:10.1002/jimd.12134.

    PMID: 31177550
  25. 25

    Mitochondrial disorders and drugs: what every physician should know.

    Orsucci D, Ienco EC, Siciliano G, Mancuso M

    Drugs in context 2019; (8()):212588 doi:10.7573/dic.212588.

    PMID: 31391854
  26. 26

    Proximal renal tubular acidosis with and without Fanconi syndrome.

    Kashoor I, Batlle D

    Kidney research and clinical practice 2019; (38(3)):267-281 doi:10.23876/j.krcp.19.056.

    PMID: 31474092
  27. 27

    THE ROLE OF HETEROPLASMY IN THE DIAGNOSIS AND MANAGEMENT OF MATERNALLY INHERITED DIABETES AND DEAFNESS.

    Robinson KN, Terrazas S, Giordano-Mooga S, Xavier NA

    Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2020; (26(2)):241-246 doi:10.4158/EP-2019-0270.

    PMID: 31682520
  28. 28

    Mitochondrial DNA heteroplasmy in disease and targeted nuclease-based therapeutic approaches.

    Nissanka N, Moraes CT

    EMBO reports 2020; (21(3)):e49612 doi:10.15252/embr.201949612.

    PMID: 32073748
  29. 29

    Heteroplasmy and Copy Number in the Common m.3243A>G Mutation-A Post-Mortem Genotype-Phenotype Analysis.

    Scholle LM, Zierz S, Mawrin C, et al.

    Genes 2020; (11(2)) doi:10.3390/genes11020212.

    PMID: 32085658
  30. 30

    Dysphagia Affecting Quality of Life in Cerebellar Ataxia-a Large Survey.

    Rönnefarth M, Hanisch N, Brandt AU, et al.

    Cerebellum (London, England) 2020; (19(3)):437-445 doi:10.1007/s12311-020-01122-w.

    PMID: 32170655
  31. 31

    Six-year prospective follow-up study in 151 carriers of the mitochondrial DNA 3243 A>G variant.

    de Laat P, Rodenburg RR, Roeleveld N, et al.

    Journal of medical genetics 2021; (58(1)):48-55 doi:10.1136/jmedgenet-2019-106800.

    PMID: 32439810
  32. 32

    Renal Tubular Acidosis.

    Bagga A, Sinha A

    Indian journal of pediatrics 2020; (87(9)):733-744 doi:10.1007/s12098-020-03318-8.

    PMID: 32591997
  33. 33

    Chronic kidney disease caused by maternally inherited diabetes and deafness: a case report.

    Tanaka K, Ueno T, Yoshida M, et al.

    CEN case reports 2021; (10(2)):220-225 doi:10.1007/s13730-020-00547-w.

    PMID: 33125665
  34. 34

    The molecular pathology of pathogenic mitochondrial tRNA variants.

    Richter U, McFarland R, Taylor RW, Pickett SJ

    FEBS letters 2021; (595(8)):1003-1024 doi:10.1002/1873-3468.14049.

    PMID: 33513266
  35. 35

    Diagnosing Mitochondrial Disorders Remains Challenging in the Omics Era.

    Forny P, Footitt E, Davison JE, et al.

    Neurology. Genetics 2021; (7(3)):e597 doi:10.1212/NXG.0000000000000597.

    PMID: 34056100
  36. 36

    Glucagon-like peptide-1 in diabetes care: Can glycaemic control be achieved without nausea and vomiting?

    Borner T, Tinsley IC, Doyle RP, et al.

    British journal of pharmacology 2022; (179(4)):542-556 doi:10.1111/bph.15647.

    PMID: 34363224
  37. 37

    Growth Retardation in the Course of Fanconi Syndrome Caused by the 4977-bp Mitochondrial DNA Deletion: A Case Report.

    Li T, Lu Z, Wang J, et al.

    Children (Basel, Switzerland) 2021; (8(10)) doi:10.3390/children8100887.

    PMID: 34682152
  38. 38

    ECMO for Metabolic Crisis in a Patient with Mitochondrial Disease.

    Sharma S, Deerman C, Andreae MH, Myler C

    Case reports in anesthesiology 2021; (2021()):9914311 doi:10.1155/2021/9914311.

    PMID: 34760322
  39. 39

    The Mutations and Clinical Variability in Maternally Inherited Diabetes and Deafness: An Analysis of 161 Patients.

    Yang M, Xu L, Xu C, et al.

    Frontiers in endocrinology 2021; (12()):728043 doi:10.3389/fendo.2021.728043.

    PMID: 34899594
  40. 40

    Molecular biomarkers correlate with brain grey and white matter changes in patients with mitochondrial m.3243A > G mutation.

    Evangelisti S, Gramegna LL, La Morgia C, et al.

    Molecular genetics and metabolism 2022; (135(1)):72-81 doi:10.1016/j.ymgme.2021.11.012.

    PMID: 34916127
  41. 41

    Neurodegenerative and functional signatures of the cerebellar cortex in m.3243A > G patients.

    Haast RAM, De Coo IFM, Ivanov D, et al.

    Brain communications 2022; (4(1)):fcac024 doi:10.1093/braincomms/fcac024.

    PMID: 35187487
  42. 42

    Effects of therapeutic exercise on disease severity, balance, and functional Independence among individuals with cerebellar ataxia: A systematic review with meta-analysis.

    Winser S, Chan HK, Chen WK, et al.

    Physiotherapy theory and practice 2023; (39(7)):1355-1375 doi:10.1080/09593985.2022.2037115.

    PMID: 35212247
  43. 43

    Peri-operative management of an adult with POLG-related mitochondrial disease.

    Valent A, Delorme L, Roland E, et al.

    Anaesthesia reports 2022; (10(1)):e12159 doi:10.1002/anr3.12159.

    PMID: 35309182
  44. 44

    Rickets guidance: part II-management.

    Haffner D, Leifheit-Nestler M, Grund A, Schnabel D

    Pediatric nephrology (Berlin, Germany) 2022; (37(10)):2289-2302 doi:10.1007/s00467-022-05505-5.

    PMID: 35352187
  45. 45

    Renal Phenotype in Mitochondrial Diseases: A Multicenter Study.

    Parasyri M, Brandström P, Uusimaa J, et al.

    Kidney diseases (Basel, Switzerland) 2022; (8(2)):148-159 doi:10.1159/000521148.

    PMID: 35527992
  46. 46

    Is Type 2 Diabetes a Primary Mitochondrial Disorder?

    Weksler-Zangen S

    Cells 2022; (11(10)) doi:10.3390/cells11101617.

    PMID: 35626654
  47. 47

    Screening and prevalence of cardiac abnormalities on electro- and echocardiography in a large cohort of patients with mitochondrial disease.

    Hendrix CLF, van den Heuvel FMA, Rodwell L, et al.

    Molecular genetics and metabolism 2022; (136(3)):219-225 doi:10.1016/j.ymgme.2022.05.004.

    PMID: 35659503
  48. 48

    Impact of measuring heteroplasmy of a pathogenic mitochondrial DNA variant at the single-cell level in individuals with mitochondrial disease.

    Imai-Okazaki A, Nitta KR, Yatsuka Y, et al.

    Journal of inherited metabolic disease 2022; (45(6)):1143-1150 doi:10.1002/jimd.12547.

    PMID: 36053827
  49. 49

    Fanconi Syndrome in an Adult With Chronic Alcohol Use Disorder: A Rare Etiology.

    Safdar S, Shahrukh S, Khan A, Shahid Z

    Cureus 2022; (14(8)):e28205 doi:10.7759/cureus.28205.

    PMID: 36158425
  50. 50

    Pathogenic mtDNA variants, in particular single large-scale mtDNA deletions, are strongly associated with post-lingual onset sensorineural hearing loss in primary mitochondrial disease.

    Elander J, McCormick EM, Värendh M, et al.

    Molecular genetics and metabolism 2022; (137(3)):230-238 doi:10.1016/j.ymgme.2022.09.002.

    PMID: 36182714
  51. 51

    Genetic testing for mitochondrial disease: the United Kingdom best practice guidelines.

    Mavraki E, Labrum R, Sergeant K, et al.

    European journal of human genetics : EJHG 2023; (31(2)):148-163 doi:10.1038/s41431-022-01249-w.

    PMID: 36513735
  52. 52

    Investigation of oxidative phosphorylation activity and complex composition in mitochondrial disease.

    Thompson K, Stroud DA, Thorburn DR, Taylor RW

    Handbook of clinical neurology 2023; (194()):127-139 doi:10.1016/B978-0-12-821751-1.00008-7.

    PMID: 36813309
  53. 53

    Mitochondrial Myopathy in a 21-Year-Old Man Presenting With Bilateral Lower Extremity Weakness and Swelling.

    Bharathidasan K, Evans A, Fernandez FMAO, et al.

    Journal of primary care & community health 2023; (14()):21501319231172697 doi:10.1177/21501319231172697.

    PMID: 37162197
  54. 54

    Physical Activity and Fitness Levels of Individuals With Ataxia: A Cross-Sectional Study.

    Barbuto S, Lee S, Stein J, et al.

    Archives of physical medicine and rehabilitation 2023; (104(10)):1669-1675 doi:10.1016/j.apmr.2023.06.007.

    PMID: 37380120
  55. 55

    Rickets in proximal renal tubular acidosis: a case series of six distinct etiologies.

    Singhania P, Dhar A, Deshpande A, et al.

    Journal of pediatric endocrinology & metabolism : JPEM 2023; (36(9)):879-885 doi:10.1515/jpem-2023-0155.

    PMID: 37434360
  56. 56

    Case report: mitochondrial diabetes mellitus in a Chinese family due to m.3243A>G.

    Bai W, Zhang Q, Fan Y, et al.

    Journal of pediatric endocrinology & metabolism : JPEM 2023; (36(8)):777-781 doi:10.1515/jpem-2023-0016.

    PMID: 37459161
  57. 57

    Complex I deficiency in m.3243A>G fibroblasts is alleviated by reducing NADH accumulation.

    Liufu T, Yu H, Yu J, et al.

    Frontiers in physiology 2023; (14()):1164287 doi:10.3389/fphys.2023.1164287.

    PMID: 37650111
  58. 58

    Inborn Errors of Metabolism with Ataxia: Current and Future Treatment Options.

    Bremova-Ertl T, Hofmann J, Stucki J, et al.

    Cells 2023; (12(18)) doi:10.3390/cells12182314.

    PMID: 37759536
  59. 59

    Anesthetic Management of a Patient With Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes Syndrome During Extensive Spinal Surgery With Both Motor Evoked Potentials and Somatosensory Evoked Potentials: A Case Report.

    Salehpoor MS, Paluska MR, Falcon R, et al.

    Cureus 2023; (15(10)):e47198 doi:10.7759/cureus.47198.

    PMID: 37854475
  60. 60

    Behavioral Management of Respiratory/Phonatory Dysfunction for Dysarthria Associated With Neurodegenerative Disease: A Systematic Review.

    Perry SE, Troche M, Huber JE, et al.

    American journal of speech-language pathology 2024; (33(2)):1069-1097 doi:10.1044/2023_AJSLP-23-00274.

    PMID: 38232176
  61. 61

    A diagnostic framework to identify vestibular involvement in multi-sensory neurological disease.

    Male AJ, Holmes SL, Koohi N, et al.

    European journal of neurology 2024; (31(5)):e16216 doi:10.1111/ene.16216.

    PMID: 38247216
  62. 62

    Acquired Fanconi syndrome in mixed cryoglobulinemia patients: a single-center case series.

    Xu Q, Chen G, Wen Y, et al.

    Clinical rheumatology 2024; (43(7)):2329-2336 doi:10.1007/s10067-024-06997-2.

    PMID: 38730122
  63. 63

    Type 2 renal tubular acidosis presenting with joint pain: A case report and literature review.

    Nuransoy Cengi Z A, Yolbaş S, Şahi N İ, et al.

    Medicine international 2022; (2(2)):11 doi:10.3892/mi.2022.36.

    PMID: 38938529
  64. 64

    Precision treatment of beta-cell monogenic diabetes: a systematic review.

    Naylor RN, Patel KA, Kettunen JLT, et al.

    Communications medicine 2024; (4(1)):145 doi:10.1038/s43856-024-00556-1.

    PMID: 39025920
  65. 65

    Administration of bicarbonates through percutaneous gastrostomy with continuous nocturnal infusion in a patient with Kearns-Sayre disease: a life changing therapeutical paradigm.

    Traunero A, Baldo F, Magnolato A, et al.

    Italian journal of pediatrics 2024; (50(1)):132 doi:10.1186/s13052-024-01696-9.

    PMID: 39075568
  66. 66

    Analysis of Mutational Burden of Mitochondrial Genome in Cells of Different Human Organs and Tissues.

    Sazonova MA, Sinyov VV, Ryzhkova AI, et al.

    Current medicinal chemistry 2025; (32(15)):3028-3043 doi:10.2174/0109298673296881240816065357.

    PMID: 39185646
  67. 67

    Auditory and vestibular function in mitochondrial patients harbouring the m.3243A>G variant.

    Stefanetti RJ, Newman J, Blain AP, et al.

    Brain communications 2024; (6(6)):fcae361 doi:10.1093/braincomms/fcae361.

    PMID: 39497799
  68. 68

    Goal-Directed Rehabilitation Versus Standard Care for Individuals with Hereditary Cerebellar Ataxia: A Multicenter, Single-Blind, Randomized Controlled Superiority Trial.

    Milne SC, Roberts M, Williams S, et al.

    Annals of neurology 2025; (97(3)):409-424 doi:10.1002/ana.27130.

    PMID: 39520242
  69. 69

    Mitochondrial disorder diagnosis and management- what the pediatric neurologist wants to know.

    Heath O, Feichtinger RG, Achleitner MT, et al.

    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 2025; (54()):75-88 doi:10.1016/j.ejpn.2024.10.009.

    PMID: 39793294
  70. 70

    Effects of physiotherapy on degenerative cerebellar ataxia: a systematic review and meta-analysis.

    Matsugi A, Bando K, Kondo Y, et al.

    Frontiers in neurology 2024; (15()):1491142 doi:10.3389/fneur.2024.1491142.

    PMID: 39866519
  71. 71

    Assessing glycaemic impact of FreeStyle libre monitoring in patients with insulin-treated type 2 diabetes: a retrospective real-world analysis.

    Atkinson M, Williams DM, Crockett E, et al.

    Journal of diabetes and metabolic disorders 2025; (24(1)):72 doi:10.1007/s40200-025-01572-1.

    PMID: 40041676
  72. 72

    Retinopathy associated with MELAS syndrome. A case report.

    González Escobar AB, Barco Moreno E, López-Egea Bueno MA, et al.

    Archivos de la Sociedad Espanola de Oftalmologia 2025; (100(4)):197-201 doi:10.1016/j.oftale.2025.03.001.

    PMID: 40058687
  73. 73

    Experiences from dual genome next-generation sequencing panel testing for mitochondrial disorders: a comprehensive molecular diagnosis.

    Gorman E, Dai H, Feng Y, et al.

    Frontiers in genetics 2025; (16()):1488956 doi:10.3389/fgene.2025.1488956.

    PMID: 40110048
  74. 74

    Case report: Reversible Fanconi syndrome due to vitamin D deficiency in a patient with epilepsy harbouring a pathogenic variant in the SLC34A1 gene.

    Improda N, Rosanio FM, Annicchiarico Petruzzelli L, et al.

    Frontiers in endocrinology 2025; (16()):1553032 doi:10.3389/fendo.2025.1553032.

    PMID: 40225330
  75. 75

    Delineating the mechanisms of cerebellar degeneration in paediatric and adult primary mitochondrial disease.

    Smith LA, Olkhova EA, Lax NZ, et al.

    Acta neuropathologica 2025; (149(1)):53 doi:10.1007/s00401-025-02891-6.

    PMID: 40445405
  76. 76

    Mitochondrial heteroplasmy-phenotype correlation and response to glucose lowering therapy in subjects with m.3243A>G mutations.

    Ng N, Sanchez-Lechuga B, McCarrick CJ, et al.

    Diabetes & metabolism 2025; (51(5)):101678 doi:10.1016/j.diabet.2025.101678.

    PMID: 40541739
  77. 77

    Unveiling long-standing low-molecular-weight proteinuria: A proximal tubular mitochondrial enzyme impairment caused by EHHADH mutation.

    Tanaka H, Imasawa T, Tsugawa K, et al.

    Pediatric nephrology (Berlin, Germany) 2026; (41(3)):675-678 doi:10.1007/s00467-025-07020-9.

    PMID: 41117969
  78. 78

    Approach to the Patient: Mitochondrial Diabetes: Contemporary Cases and a Precision Medicine Approach.

    Oppenheimer KR, Himelhoch NT, McCullough ME, et al.

    The Journal of clinical endocrinology and metabolism 2026; (111(4)):1175-1186 doi:10.1210/clinem/dgaf698.

    PMID: 41472381
  79. 79

    Comprehensive Phenotype and Treatment Description of Mitochondrial Diabetes: Insights From a Large Cohort Study.

    Plaza Enriquez L, Ibrahim R, Ayari L, et al.

    Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2026; (32(6)):909-915 doi:10.1016/j.eprac.2026.01.010.

    PMID: 41621650
  80. 80

    Diagnostic Criteria and Management of MELAS and Stroke-Like Episodes: Consensus-Based Statements.

    Mancuso M, Bellusci M, Carelli V, et al.

    European journal of neurology 2026; (33(4)):e70588 doi:10.1111/ene.70588.

    PMID: 41999163
  81. 81

    Glucagon-Like Peptide-1 Receptor Agonists in the Management of Mitochondrial Diabetes in an Adolescent: A Case Report.

    Hayes E, Nillsen A, Rowe PW, et al.

    Hormone research in paediatrics 2026; 1-9 doi:10.1159/000552014.

    PMID: 41999618
  82. 82

    Co-prescription of metformin and glucagon-like peptide-1 receptor agonists and metformin-associated lactic acidosis: A case series.

    Hussain H, Ali M, Lorlowhakarn K, et al.

    Clinical nephrology. Case studies 2026; (14()):39-45 doi:10.5414/CNCS111965.

    PMID: 42164410
  83. 83

    Prevalence and treatment of mitochondrial diabetes in Southwest Finland.

    Rindell N, Immonen H, Martikainen MH

    Journal of diabetes and metabolic disorders 2026; (25(1)):154 doi:10.1007/s40200-026-01964-x.

    PMID: 42255315
  84. 84

    Patient-Derived Fibroblasts as a Clinically Relevant Model of Kearns-Sayre Syndrome.

    Valls-Roca L, Vilaseca-Capel A, Cantó-Santos J, et al.

    Annals of neurology 2026; doi:10.1002/ana.78351.

    PMID: 42753134
  85. 85

    Toward Understanding the Molecular Basis and Precise Diagnosis of Mitochondrial Diabetes: A Comprehensive Review.

    Skoczylas S, Banach K, Zmysłowska A

    The Yale journal of biology and medicine 2026; (99(3)):466-487 doi:10.59249/GBKY6240.

    PMID: 43005028